NORTHERN TRUST CORP - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 225 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$9,356,441
-60.9%
998,553
+2.2%
0.00%
-60.0%
Q2 2023$23,959,554
+18.8%
976,745
+12.7%
0.01%
+25.0%
Q1 2023$20,160,663
+2.3%
866,380
+11.3%
0.00%0.0%
Q4 2022$19,708,871
+23.1%
778,699
-6.3%
0.00%0.0%
Q3 2022$16,015,000
-26.4%
830,664
-2.8%
0.00%
-20.0%
Q2 2022$21,762,000
+38.4%
854,403
+39.8%
0.01%
+66.7%
Q1 2022$15,724,000
-39.4%
611,327
-1.3%
0.00%
-25.0%
Q4 2021$25,939,000
-4.3%
619,507
-0.5%
0.00%
-20.0%
Q3 2021$27,098,000
-12.0%
622,649
-4.4%
0.01%0.0%
Q2 2021$30,792,000
-0.7%
651,260
+7.7%
0.01%
-16.7%
Q1 2021$30,999,000
+81.7%
604,621
-5.1%
0.01%
+100.0%
Q4 2020$17,058,000
-24.1%
637,013
-2.7%
0.00%
-40.0%
Q3 2020$22,481,000
+11.8%
654,821
+33.4%
0.01%0.0%
Q2 2020$20,107,000
+437.0%
490,789
+349.3%
0.01%
+400.0%
Q1 2020$3,744,000
+181.5%
109,228
+3.3%
0.00%
Q4 2019$1,330,000105,7520.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$30,100,00023.79%
SB INVESTMENT ADVISERS (UK) LTD 22,086,280$425,823,0003.26%
Zebra Capital Management LLC 40,104$773,0002.94%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 130,409$2,514,0000.94%
CLARK ESTATES INC/NY 180,000$3,470,0000.77%
Temasek Holdings (Private) Ltd 6,036,821$116,389,9090.70%
SECTOR GAMMA AS 89,808$1,731,0000.45%
Capital Impact Advisors, LLC 13,196$360,0000.36%
SummerHaven Investment Management, LLC 24,927$481,0000.33%
DUALITY ADVISERS, LP 92,712$1,787,0000.20%
View complete list of VIR BIOTECHNOLOGY INC shareholders